Sierra Oncology, Inc. Skyrocketed

Thu, Apr 14, 2022 at 05:30 PM
Sierra Oncology, Inc. Skyrocketed

Sierra Oncology, Inc. (SRRA:NASDAQ) jumped higher at $54.75, a gain of 38.5%. On Wed, Apr 13, 2022, SRRA:NASDAQ hit a New 2-Week High of $54.75. The stock appeared on our News Catalysts scanner on Thu, Apr 14, 2022 at 04:46 PM in the 'BIOTECH' category. From Wed, Mar 30, 2022, the stock recorded 80.00% Up Days and 63.64% Green Days

About Sierra Oncology, Inc. (SRRA:NASDAQ)

Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.